SCHEMBL6907375

SCHEMBL6907375

CCC(=O)NC(=O)CNc1cccc(O)c1

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
CYP1A2 P05177 1/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
LMNA P02545 2/20 0.47
NLRP3 Q96P20 9/20 0.46
SYK P43405 1/20 0.45
POLB P06746 1/20 0.44
NR4A1 P22736 1/20 0.44
RAB9A P51151 1/20 0.44
GAA P10253 2/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6907026 0.86 ALDH1A1 (0.57) ALDH1A1CYP1A2MEN1KMT2ALMNA
SCHEMBL11319121 0.82 SYK (0.59) ALDH1A1CYP1A2MEN1KMT2ALMNA
SCHEMBL6908850 0.82 GAA (0.51) ALDH1A1MEN1KMT2ALMNARAB9A
SCHEMBL6901540 0.80 ALDH1A1 (0.47) ALDH1A1CYP1A2MEN1KMT2ALMNA
SCHEMBL21834459 0.79 ALDH1A1 (0.51) ALDH1A1CYP1A2MEN1KMT2ALMNA
SCHEMBL6906987 0.79 MEN1 (0.50) ALDH1A1MEN1KMT2ALMNAPOLB
SCHEMBL6360996 0.78 RAB9A (0.69) ALDH1A1CYP1A2MEN1KMT2ALMNA
SCHEMBL9525972 0.77 GAA (0.54) ALDH1A1CYP1A2MEN1KMT2ANLRP3
Hydrochloric Acid SCHEMBL11309314 0.76 CYP3A4 (0.52) ALDH1A1CYP1A2MEN1KMT2ALMNA
SCHEMBL150832 0.76 CYP3A4 (0.52) ALDH1A1CYP1A2MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US claimed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP claimed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US claimed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO claimed
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US disclosed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP disclosed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US disclosed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives GRHPR, ARL1, SUCLG1 ALDH1A1 1110/4885CYP1A2 3234/4885MEN1 3723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.